Information requirement | Use |
---|---|
Number of people exposed | Control Measures |
 |    • Implementation of screening procedures |
 |    • Determination of amount of drugs/vaccine |
 |    • Deployment of drugs/vaccine/antidotes |
 | Follow-up |
 |    • Number of people exposed |
 |    • People who are receiving chemoprophylaxis |
 |    • Centers providing follow up services and number of patients lost |
 |    • Loss of follow-up |
Line listings | During the initial investigation |
 |    • Case finding |
 |    • Identification of people at risk |
 |    • People who did not report to work/school |
 |    • People admitted to hospitals that meet case definition |
 |    • People who did not attend screening programs |
 |    • People not receiving post exposure prophylaxis(PEP) |
 | During PEP |
 |    • Dissemination of information such as screening test, changes in PEP protocols, |
 |    • Changes in facilities available for screening/treatment |
 |    • Changes in recommendations |
 |    • Case finding if the definition of exposed changes based on preliminary data |
 | After the control measures are implemented |
 |    • Follow-up of adverse reactions |
 |    • Follow-up of special populations such as pregnant women and children |
 |    • Suspected cases under investigation |
 |    • Cases ruled out |
 |    • Cases ruled in |
Clinical information | During Initial Investigation |
 |    • Location of suspected cases |
 |    • Location of confirmed cases |
 |    • Status of confirmatory test |
 |    • Clinical condition of cases |
 | Follow-up |
 |    • Clinical status |
 |    • Disposition |
Geographic Information Systems | Base Data |
 |    • Floor plan map linkable to databases |
 | Case finding |
 |    • County/Zip code of exposed populations |
 |    • Hospital locations |
 |    • Driving directions to hospitals, operation centers, and affected facilities |
 | Surveillance |
 |    • The number and location of emergency rooms |
 |    • Hospitals included in the surveillance system |
 |    • Sentinel sites |
 | Environmental |
 |    • Distribution of the sampling |
 |    • Proportion of positive samples |
 |    • Extension of the contamination |
 | Epidemiology |
 |    • Spatial relationship between cases and exposed population |
 |    • Identification of unexposed populations |
 |    • Identification of exposed population not included during the initial assessment |
 |    • Distribution of cases |
 |    • Distribution of deaths |
 |    • Geographic distribution patterns |
Guidelines | Guidelines for treatments |
 |    • Frequently asked questions(FAQ) for the emergency response center |
 |    • FAQ for the press |
 |    • Recommendation for clinicians |
 |    • Guidelines for staff |
 |    • Elements of information necessary |
 |    • Software algorithms implemented in other locations |
 |    • Sensitivity and specificity of screening methods |
Documentation | During the initial investigation |
 |    • Drafts for guidelines in different versions |
 |    • Drafts for paper forms to be used in all stages of the investigation |
 |    • Customized reports |
Laboratory Results | During the case finding |
 |    • Number of samples in the laboratory |
 |    • Number of positive samples |
 |    • Results of confirmatory tests |
 |    • Laboratories involved |
 |    • Discrepancies between laboratories |
Logistics | During the whole operation |
 |    • Team list |
 |    • Cell phones |
 |    • Email addresses |
 |    • Distribution by hotel, team, activities |
 |    • Emergency contact numbers |